Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / A•••• B•••••••••

A•••• B•••••••••

Series CUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$50.0Msum of rounds with a disclosed amount only
Named investors
6
Financing history
1 rounds
  1. May 18, 2026
    Series C · $50.0M (disclosed)
    C••••• C•••••• (participant)O•••••• A••••••• L•• (lead)T••• (participant)L•• (participant)T•• C•••••••• (participant)O•••• H••••••• (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “A•••• B••••••••• Announces $50 Million Series C Financing Led by O•••••• to Advance Clinical Pipeline for Immune Mediated Diseases”
Investors on record
6 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. May 18, 2026
    A•••• B••••••••• announced Series C of $50,000,000, led by O••••••
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company